Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter S. Ringrose currently holds 37,999 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter S. Ringrose has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Peter S. Ringrose's most recent insider trade was on Apr 30, 2019, when they sold 8,385 shares at $0.00 per share.
Peter S. Ringrose serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Peter S. Ringrose holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Peter S. Ringrose has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter S. Ringrose was on Apr 30, 2019, when they purchased $0 worth of TBPH shares. This transaction involved 8,385 shares at N/A per share.
Peter S. Ringrose currently owns 37,999 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter S. Ringrose's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter S. Ringrose has 10 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Peter S. Ringrose and 40,000+ other insiders.